市场调查报告书
商品编码
1423182
2024-2032 年按产品、解决方案、应用、组件、部署和地区分類的 3D 医学影像设备市场报告3D Medical Imaging Equipment Market Report by Product, Solution, Application, Component, Deployment, and Region 2024-2032 |
2023年全球3D医学影像设备市场规模达到131亿美元。展望未来, IMARC Group预计到2032年市场规模将达到197亿美元,2024-2032年复合年增长率(CAGR)为4.5%。
医学影像是一种创建体内内部器官的视觉描述的技术,用于疾病的临床诊断及其后续的医疗。 3D 影像技术可帮助医疗保健专业人员捕捉多个角度的影像并显示不同深度的组织,同时增强解析度和更复杂的细节,以便更好地了解人体。与先前使用的可能产生错误结果的成像技术不同,3D 成像技术可以在诊断任何医疗疾病时提供精确的资讯。事实证明,它在各种医学疾病的诊断中具有革命性的意义,其中包括对乳癌治疗至关重要的数位乳房断层合成 (DBT)
蓬勃发展的医疗保健产业是推动市场成长的关键因素之一。由于久坐的生活方式和老年人口的显着增加,生活方式疾病和与年龄相关的疾病的发生率均增加。因此,这增加了医疗保健领域对 3D 医学影像设备的需求。此外,技术的进步,加上人们对该技术的好处的认识不断提高,例如内臟器官的准确视觉表示、对周围组织的损伤减少以及各种医学成像程序提供的资料的准确性,刺激了市场的增长。全球各国政府不断增加的医疗保健预算拨款和研发 (R&D) 活动进一步推动了市场的发展。
The global 3D medical imaging equipment market size reached US$ 13.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.
Medical imaging is a technique of creating visual depictions of internal organs in the body for the clinical diagnosis of an ailment and its subsequent medical treatment. The 3D imaging technology has aided healthcare professionals to capture images at multiple angles and display tissues at varying depths along with enhanced resolutions and more intricate details to provide a better understanding of the human body. Unlike previously used imaging technologies which had possibilities of erroneous results, the 3D imaging technology offers precise information during the diagnosis of any medical ailment. It has proved revolutionary in the diagnosis of various medical illnesses, including digital breast tomosynthesis (DBT), which is crucial in the treatment of breast cancer
The thriving healthcare industry is one of the key factors driving market growth. There has been a rise in the occurrence of lifestyle diseases along with age-related ailments owing to sedentary lifestyles and a significant increase in the geriatric population, respectively. This has consequently bolstered the demand for 3D medical imaging equipment in the healthcare sector. Moreover, technological advancements coupled with the rising awareness about the benefits of this technology such as an accurate visual representation of internal organs, reduced damage to surrounding tissues and accuracy of data offered by various medical imaging procedures has stimulated the market growth. The market is further driven by increasing healthcare budgetary allocations and research and development (R&D) activities by governments of various nations across the globe.
IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D medical imaging equipment market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product, solution, application, component and deployment.
X-Ray
Ultrasound
MRI
CT Scan
Hybrid Imaging
3D Scanning
3D Rendering
3D Modeling
Oncology
Cardiology
Orthopedics
Others
Hardware
Software
Service
On-Premise Based Platform
Cloud Based Platform
Web Based Platform
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being GE Healthcare, Philips Electronics Nederland B.V., Siemens Healthineers, FUJIFILM Corporation, Analogic Corporation, ContextVision AB, Dentsply Sirona, EOS imaging, Esaote S.p.A, Fuel 3D Technologies Limited, KaVo Dental GmbH, Hologic, Inc., Intelerad Medical Systems, Planmeca Group, Samsung Medison and Shimadzu Corporation.
IMARC Group's latest report provides a deep insight into the global 3D medical imaging equipment market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global 3D medical imaging equipment market in any manner.